[DNLI] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
26-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 520.56%
YoY- 553.28%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 5,285 22,939 7,923 316,815 9,393 5,847 3,604 29.04%
PBT -84,588 -60,691 -70,041 245,708 -58,172 -58,679 -56,898 30.22%
Tax 782 728 -2,108 823 56 79 -135 -
NP -84,588 -60,691 -70,041 244,885 -58,228 -58,758 -56,763 30.43%
Tax Rate - - - -0.33% - - - -
Total Cost 89,873 83,630 77,964 71,930 67,621 64,605 60,367 30.35%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -1,600.53 -264.58 -884.02 77.30 -619.91 -1,004.93 -1,575.00 1.07%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.69 -0.50 -0.58 2.04 -0.54 -0.56 -0.55 16.30%
EPS Diluted -0.69 -0.49 -0.58 1.91 -0.54 -0.56 -0.55 16.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.